Haemacure and Baxter reach settlement:
This article was originally published in Clinica
Executive Summary
Canadian biomaterial company Haemacure has reached a C$2.3 million ($1.5 million) settlement with Baxter International, the supplier of Hemaseel APR fibrin sealant, payable to Haemacure. The settlement amount was credited against the licence fee of C$3.8 million payable to Baxter. The dispute concerned the cost of the product and other financial issues in the companies' manufacturing agreement. The cost review was carried out by a trustee appointed by the US Federal Trade Commission at Haemacure's request. The two companies have also agreed fixed prices for the remainder of the manufacturing agreement.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.